About Psilocydia
Psilocydia is a company based in Beverly (United States) founded in 2022 by Kevin McKernan. It operates as a B2B and SaaS. Psilocydia offers products and services including Kannapedia Database, Cultivar Reports, and Blockchain Stamping. Psilocydia operates in a competitive market with competitors including Genomenon, RareCan, Yaorongyun Digital Technology, Partex and Wuxu Data, among others.
- Headquarter Beverly, United States
- Founders Kevin McKernan
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Medicinal Genomics Corporation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Psilocydia
Psilocydia offers a comprehensive portfolio of products and services, including Kannapedia Database, Cultivar Reports, and Blockchain Stamping.
Public database for cannabis and hemp strain data
Reports on cannabis genetics and high-impact variants
Tool for securing strain genetics on blockchain
Funding Insights of Psilocydia
Detailed funding history for Psilocydia
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Psilocydia
Investment portfolio details for Psilocydia
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Psilocydia
Detailed financials for Psilocydia
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Psilocydia Comparisons
Peer comparison for Psilocydia
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Psilocydia
Psilocydia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Genomenon, RareCan, Yaorongyun Digital Technology, Partex and Wuxu Data, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based bioinformatics tools and genomic variants meta-database are developed.
|
|
| Locked | Locked | Locked |
Cancer patient data is collected online for clinical trial researchers.
|
|
| Locked | Locked | Locked |
Provider of an online healthcare database platform
|
|
| Locked | Locked | Locked |
Partex is focused on revolutionizing drug development with technology.
|
|
| Locked | Locked | Locked |
Medical information is delivered online for pharmaceutical sectors.
|
|
| Locked | Locked | Locked |
Platform for sharing research manuscripts, data, code, and AI insights.
|
Detailed competitors of Psilocydia
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Psilocydia
Complete news archive for Psilocydia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Psilocydia
Psilocydia was founded in 2022.
Psilocydia is headquartered in Beverly, United States. It is registered at Beverly, Massachusetts, United States.
Kevin McKernan is the current CEO of Psilocydia. They have also founded this company.
Kannapedia, a service by Medicinal Genomics, operates as a comprehensive public database containing over 2239 registered cannabis and hemp strains. It offers genetic reports, blockchain stamping for IP protection, and tools for analyzing terpenes, cannabinoids, and disease resistance. Based in Beverly, MA, USA, it serves researchers, cultivators, and businesses by providing accessible data for strain comparison and quality assurance, while ensuring secure and reliable genetic information.
Psilocydia's top competitors include Genomenon, Yaorongyun Digital Technology and RareCan.
Psilocydia offers Kannapedia Database, Cultivar Reports, and Blockchain Stamping.